TCM
CORZW icon

Triumph Capital Management’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Triumph Capital Management’s Portfolio CORZW Stock Details CORZW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19 Hold
1
– – ﹤0.01% 1851
2026
Q1 		$9 Hold
1
– – ﹤0.01% 1831
2025
Q4 		$8 Buy
+1
New +$11 ﹤0.01% 1766

Other funds holding CORZW

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $465M AUM 58.97% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Triumph Capital Management's CORZW Position: Q2 2026 in Review

Triumph Capital Management held its Core Scientific Inc Tranche 1 Warrants (CORZW) position steady in Q2 2026 at 1 share worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Triumph Capital Management first reported a position in CORZW in Q4 2025 and has held it in 3 quarters since. 61 funds tracked by Wall St. Rank hold CORZW as of Q2 2026.

  • Triumph Capital Management held 1 share of Core Scientific Inc Tranche 1 Warrants worth $19 as of Q2 2026.
  • Triumph Capital Management left its Core Scientific Inc Tranche 1 Warrants share count unchanged in Q2 2026.
  • Core Scientific Inc Tranche 1 Warrants made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1851 holding.
  • Triumph Capital Management first reported a position in Core Scientific Inc Tranche 1 Warrants in Q4 2025 and has held it in 3 quarters since.
  • 61 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.